First Trust Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.91M | Sell |
|
|||||
|
2024
Q3 | $5.1M | Buy |
|
|||||
|
2024
Q2 | $2.21M | Sell |
|
|||||
|
2024
Q1 | $2.49M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $794K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $511K | Buy |
|
|||||
|
2022
Q2 | $426K | Sell |
|
|||||
|
2022
Q1 | $760K | Sell |
|
|||||
|
2021
Q4 | $2.29M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $381K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $648K | Sell |
|
|||||
|
2018
Q4 | $1.44M | Sell |
|
|||||
|
2018
Q3 | $4.01M | Buy |
|
|||||
|
2018
Q2 | $492K | Sell |
|
|||||
|
2018
Q1 | $1.09M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $426K | Sell |
|
|||||
|
2017
Q2 | $47.6M | Sell |
|
|||||
|
2017
Q1 | $36.8M | Buy |
|
|||||
|
2016
Q4 | $24.2M | Buy |
|
|||||
|
2016
Q3 | $17.9M | Buy |
|
|||||
|
2016
Q2 | $22.7M | Sell |
|
|||||
|
2016
Q1 | $28.3M | Sell |
|
|||||
|
2015
Q4 | $114M | Sell |
|
|||||
|
2015
Q3 | $138M | Sell |
|
|||||
|
2015
Q2 | $147M | Buy |
|
|||||
|
2015
Q1 | $118M | Buy |
|
|||||
|
2014
Q4 | $98M | Sell |
|
|||||
|
2014
Q3 | $119M | Buy |
|
|||||
|
2014
Q2 | $111M | Buy |
|
|||||
|
2014
Q1 | $79.6M | Buy |
|
|||||
|
2013
Q4 | $37.6M | Buy |
|
|||||
|
2013
Q3 | $35M | Buy |
|
|||||
|
2013
Q2 | $23.1M | Buy |
|